| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start. This complexity arises from rigorous study ...

Despite having a robust drug development pipeline, lupus remains far behind other rheumatic and autoimmune conditions for which dozens of targeted therapies have been developed. Addressing the ...

The pharmaceutical industry has long been reliant on rigorous research and development processes to bring life-saving drugs to market. However, the traditional methods of drug development are ...

“While targeting areas of unmet need inherently involves greater complexity and risk than incremental improvements on launched drugs and are more time consuming both in development and through ...

As part of drug-development campaigns, firms routinely determine multiple structures for the same protein bound to many different drug candidates. AlphaFold’s new rival? Meta AI predicts shape ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

The Master of Science degree program in Drug Discovery & Development (DDD) offers students the opportunity to understand, evaluate and engage with the entire process of drug discovery and development.